A hypertension management protocol from an integrated healthcare system was successfully adopted by a network of safety-net clinics, resulting in substantial improvements in blood pressure control for patients of all races.
The FDA on Friday, July 13, joined more than 20 other countries in recalling medications containing valsartan, an active ingredient used to treat hypertension and heart failure. Some of the medications with valsartan have been contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen.
Adoption of the new 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines would result in a “substantial” increase in the prevalence of hypertension in both the U.S. and China.
Valsartan, a common drug used to control hypertension and heart failure, is being recalled in 22 counties due to concerns its active pharmaceutical ingredient, N-Nitrosodimethylamine (NDMA), a known carcinogen, poses a cancer risk.
A program designed to help hypertensive patients with complex medication regimens understand the drugs they are prescribed not only failed to improve adherence, but it actually raised their blood pressure.
Patients with resistant hypertension and obstructive sleep apnea (OSA) experienced significant drops in blood pressure and improvements in OSA severity following renal denervation, according to a small randomized trial published June 25 in Hypertension.
According to a new study published in the Journal of the American College of Cardiology, women with preeclampsia with severe features (PEC) have higher right ventricular (RV) systolic pressure (RVSP) and decreased global right ventricular longitudinal systolic strain (RVLSS), among other adverse cardiovascular events, compared to women not exhibiting preeclampsia during pregnancy.
Sleep disturbances, including poor sleep quality and insomnia, are associated with increased blood pressure and vascular inflammation in women, according to a June 9 study in the Journal of the American Heart Association.
A new study published in Hypertension suggests tailoring blood pressure (BP) treatment to a patient’s exercise level may help, because people with elevated but controlled hypertension saw an increase in BP during physical activity.
Frequent binge drinkers—particularly men—are more likely to have cardiovascular risk factors such as hypertension and high cholesterol, according to a new study published in the Journal of the American Heart Association.